You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine Tumours

Showing 1 - 25 of 1,867
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Development of New Personalised 3D Preclinical Models of

Recruiting
  • Pancreatic Neuroendocrine Tumor
    • Milan, MI, Italy
      IRCCS San Raffele Institute
    Nov 2, 2023

    Gastroenteropancreatic Neuroendocrine Tumours

    Recruiting
    • Gastroenteropancreatic Neuroendocrine Tumor
    • 68Ga-DOTATOC PET as a part of their clinical diagnostic work-up will be included
    • Milano, Italy
      Irccs San Raffaele
    Nov 24, 2023

    Neuroendocrine Tumors Trial in Innsbruck (68Ga-DOTA-MGS5)

    Completed
    • Neuroendocrine Tumors
    • Innsbruck, Austria
      Department of Nuclear Medicine, Medical University of Innsbruck
    Nov 24, 2023

    Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

    Recruiting
    • Neuroendocrine Tumours (NET)
    • Neuroendocrine Carcinomas (NEC)
    • Santiago De Compostela, Galicia, Spain
    • +4 more
    Aug 1, 2022

    Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

    Not yet recruiting
    • Small Cell Lung Carcinoma (SCLC)
    • Neuroendocrine Neoplasms
    • (no location specified)
    May 25, 2023

    Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided

    Recruiting
    • Neuroendocrine Tumor of Pancreas
    • Multiple Endocrine Neoplasia Type 1
    • High-dose-high precision MR-guided radiotherapy
    • Utrecht, Netherlands
      UMC Utrecht
    May 29, 2022

    HRQoL During PRRT in Patients With NETs

    Completed
    • Neuroendocrine Tumors
    • +2 more
      • (no location specified)
      Jun 16, 2022

      Neuroendocrine Tumors, Liver Metastases Trial in London (TheraSpheres Selective Internal Radiation Therapy (SIRT))

      Recruiting
      • Neuroendocrine Tumors
      • Liver Metastases
      • TheraSpheres Selective Internal Radiation Therapy (SIRT)
      • London, United Kingdom
        Imperial College NHS Trust
      Mar 8, 2022

      Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

      Terminated
      Has Results
      • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
      • Bruxelles, Belgium
      • +23 more
      Dec 21, 2022

      Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

      Recruiting
      • Pancreatic Neuroendocrine Tumor
      • peptide receptor radionuclide therapy with Y-90-DOTATOC
      • Milano, Italy
      • +1 more
      Sep 30, 2022

      United Kingdom Patient Preference Study of Somatuline Autogel

      Completed
      • Neuroendocrine Tumours (NET)
        • Birmingham, United Kingdom
        • +4 more
        Jul 5, 2022

        Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

        Not yet recruiting
        • Small Cell Lung Carcinoma (SCLC)
        • Neuroendocrine Neoplasms
        • BI 764532
        • [89Zr]Zr-BI 764532
        • (no location specified)
        Jul 31, 2023

        Neuroendocrine Tumors Trial in Australia (64Cu-SARTATE)

        Recruiting
        • Neuroendocrine Tumors
        • Kingswood, New South Wales, Australia
        • +3 more
        May 17, 2022

        Viewpoints on Social Representations and Rationale Concerning

        Terminated
        • Non-resectable Metastatic Cancer of the Lung
        • +7 more
        • Interviews
        • Questionnaires
        • Dijon, France
          Chu Dijon Bourogne
        Apr 14, 2022

        Neuroendocrine Tumours, Neuroendocrine Tumour of the Lung, Small Intestinal NET Trial in Worldwide (Surufatinib)

        Recruiting
        • Neuroendocrine Tumours
        • +2 more
        • Atlanta, Georgia
        • +18 more
        Mar 10, 2022

        Neuroendocrine Tumors Trial in Melbourne (Talazoparib)

        Recruiting
        • Neuroendocrine Tumors
        • Melbourne, Victoria, Australia
          Peter MacCallum Cancer Centre
        Sep 20, 2021

        Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck, Colorectal Cancer Trial in Omaha

        Recruiting
        • Pancreatic Ductal Adenocarcinoma (PDAC)
        • +6 more
        • Omaha, Nebraska
          Urology Cancer Center/XCancer
        Nov 29, 2022

        Carcinoma, Neuroendocrine Trial in Edmonton ([177]Lu-DOTA-TATE)

        Recruiting
        • Carcinoma, Neuroendocrine
        • Edmonton, Alberta, Canada
          Cross Cancer Institute
        Apr 12, 2021

        Gastroenteropancreatic Neuroendocrine Tumor Trial in China (Lanreotide autogel)

        Completed
        • Gastroenteropancreatic Neuroendocrine Tumor
        • Lanreotide autogel
        • Sichuan, Chengdu, China
        • +13 more
        Jan 16, 2023

        Effectiveness and Outcomes Associated With Lutathera Treatment

        Active, not recruiting
        • Gastroenteropancreatic Neuroendocrine Tumor
        • Alessandria, Italy
        • +17 more
        May 4, 2022

        Neuroendocrine Carcinoma Trial in London (Lu-DOTA-TATE)

        Active, not recruiting
        • Neuroendocrine Carcinoma
        • Lu-DOTA-TATE
        • London, Ontario, Canada
          London Health Sciences Centre
        Apr 5, 2022

        Neuroendocrine Tumors Trial in China (Lutetium[177Lu] Oxodotreotide Injection, Octreotide LAR)

        Not yet recruiting
        • Neuroendocrine Tumors
        • Lutetium[177Lu] Oxodotreotide Injection
        • Octreotide LAR
        • Beijing, Beijing, China
        • +20 more
        Jul 25, 2022

        Neuroendocrine Tumors Trial in Worldwide (177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, CAPTEM (Capecitabine

        Recruiting
        • Neuroendocrine Tumors
        • 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT
        • +4 more
        • Palo Alto, California
        • +30 more
        Dec 14, 2022

        Neuroendocrine Tumors Metastatic to the Liver Trial in Woodville (Rose bengal disodium)

        Unknown status
        • Neuroendocrine Tumors Metastatic to the Liver
        • Rose bengal disodium
        • Woodville, South Australia, Australia
          The Queen Elizabeth Hospital
        Oct 6, 2020

        Neuroendocrine Tumors Trial in Edmonton ([68]Ga-HA-DOTATATE)

        Recruiting
        • Neuroendocrine Tumors
        • Edmonton, Alberta, Canada
          Cross Cancer Institute
        Jun 18, 2021